More and more evidence supports that YTHDF1 acts as an oncogene by affecting signaling pathways in cancers, including HCC [84], breast cancer [85], NSCLC [86], CRC [87], and Merkel cell carcinoma [88]. The gene discussed is YTHDF1; the disease is non-small cell lung carcinoma.